Core Viewpoint - The company Yueshen Health (002162) is currently facing challenges, including a recent decline in stock price and ongoing efforts to address accumulated losses through the use of reserve funds [1][2]. Group 1: Stock Performance - As of September 3, 2025, Yueshen Health's stock closed at 4.37 yuan, down 2.02% with a turnover rate of 2.03% [1]. - The trading volume was 186,300 shares, resulting in a transaction amount of 82.2565 million yuan [1]. Group 2: Financial Recovery Efforts - The company announced on May 27 that it would use reserve funds to offset losses, which would reduce the accumulated losses of the parent company by 213,911,172.05 yuan [1]. - The progress of this financial recovery effort is still ongoing, as indicated by the company's secretary [1]. Group 3: Capital Flow - On September 3, the net outflow of main funds was 759.32 million yuan, while retail investors saw a net inflow of 1,036.68 million yuan [2]. - Additionally, speculative funds experienced a net outflow of 277.36 million yuan [2].
股市必读:悦心健康(002162)9月3日董秘有最新回复